Venn Life Sciences Holdings PLC Contracts for EUR4.1m with US Biotech client (7804I)

TIDMVENN

RNS Number : 7804I

Venn Life Sciences Holdings PLC

30 March 2015

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

Contracts worth EUR4.1m signed with US Biotech client

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces today the signing of new contracts worth over EUR4.1m with a leading US based Biotechnology client.

The deals are an extension of an existing contract which has doubled in size and the award of a new clinical trial to the value of EUR2.7m. These Phase II clinical trials, that evaluate the efficacy of a pioneering drug in the areas of Oncological hematology and Respiratory, will run over 24 months in multiple European and US sites. Venn has extensive experience in the management of Phase II trials with a history of over 25 years running studies throughout Europe.

Speaking about the agreement, Venn CEO, Tony Richardson stated: "The signing of these contracts is a compliment to all the team at Venn who have been diligently working with this client since last year. It reinforces our commitment to consistently deliver excellent international services and our ability to win larger projects from global clients. We are clearly seeing tangible results from our key investments over the course of 2014."

Enquiries:

 
Venn Life Sciences Holdings       www.vennlifesciences.com 
 Plc 
Tony Richardson, Chief Executive      Tel: +353 154 99 341 
 Officer 
Orla Mc Guinness, Marketing          Tel: +33 676 93 11 78 
 Manager 
Zeus Capital (Nominated Adviser         Tel: 0161 831 1512 
 and Broker) 
 Ross Andrews/Andrew Jones 
Alex Davies                             Tel: 020 7533 7727 
Walbrook PR Ltd                   Tel: +44 (0)20 7933 8780 
                                    or venn@walbrookpr.com 
Paul McManus                      Mob: +44 (0)7980 541 893 
Lianne Cawthorne                  Mob: +44 (0)7584 391 303

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

CNTPKCDBQBKDBNB

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024